Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Feb 20, 2014

29777_dirs_2014-02-19_36034c7d-c069-4c69-84b5-50cfc9905a5f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-15

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-15 Common shares without par value F 151 $38.81 Disposed 1915 Indirect
2014-02-17 Common shares without par value F 101 $38.81 Disposed 1814 Indirect
2014-02-18 Common shares without par value F 126 $38.81 Disposed 1688 Indirect
2014-02-18 Common shares without par value S 621 $38.955 Disposed 1067 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 23733 Direct
Common shares without par value 20 Indirect
Common shares without par value 63903 Indirect
Common shares without par value 16 Indirect
Common shares without par value 12081 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2014.

F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F3: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F4: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.